Authors: M. Havlín Authors‘ workplace: ADC Sanatorium, Praha, vedoucí MUDr. P. Lippert Published in: Prakt. Lék. 2005; 85(12): 706-708 Category: Therapy
Objective: To evaluate influence of hormonal contraceptive drospirenone on premenstrual syndrome (PMS).
Design: Overall summary of literature.
Author affiliation: ADC Sanatorium, Praha.
Methods: Review of scientific studies and publications.
Conclusions: The author submitted current opinions on premenstrual syndrome, its classification, and treatment. The role of renin – aldosterone system in the genesis of PMS was described. Basic pharmacological characteristics of the remedy containing in one pill 30 μg of Ethinyl Estradiol (EE) and 3 mg of drospirenone are presented. Its therapeutic effects on somatic and psychological PMS symptoms are discussed.
Key words: premenstrual syndrome – body weight – oedema – drospirenone.
Don‘t have an account? Create new account
Enter the email address that you registered with. We will send you instructions on how to set a new password.
